Even when these therapies showed a certain reduction of hyperglycaemia, only the combination of anti-TCR with anti-TNF-α provided this desired sustained curative effect, documented by a regain of an infiltration-free pancreas with sufficient beta cell mass along with a sustained fully normalized blood glucose profile. This evidence concerns the gene TNF and Hyperglycemia.